會議議程

Executive Summary：
宋醫師目前在國立成功大學醫學院附設醫院擔任神經部臨床副教授及主治醫師，主要專長為急性腦中風臨床照護、退化性疾病及區域中風系統建置。宋醫師長期參與台南及雲嘉地區中風網絡的規劃與資料分析，主導發展「急性腦中風取栓轉診系統（EVT Transfer System, EVTTS）」建立與發展，提升區域轉診效率與治療可近性。
她的研究興趣涵蓋急性缺血性中風的再灌流治療、院間轉診模式、以及AI與數位健康技術在中風照護的應用，多篇成果發表於國際期刊如 Stroke、Journal of NeuroInterventional Surgery 等，並多次受邀於國際會議分享經驗。宋醫師同時也積極投入教學與青年醫師培育，致力於推動臨床創新與跨院區合作，共同促進台灣中風照護品質的整體提升。

Lecture Abstract：
Endovascular thrombectomy (EVT) has become the standard of care for acute ischemic stroke caused by large vessel occlusion (LVO). Optimizing treatment timeliness through regional stroke systems and interhospital collaboration remains a critical challenge.
This topic will introduce current models of regionalized acute stroke care, with a focus on the real-world implementation and challenges of different triage strategies, including the mothership, drip-and-ship approaches. Key issues to be discussed include the diagnostic accuracy of emergency medical services (EMS) in the mothership model, resource allocation for EVT-capable centers, and common causes of delay during interhospital transfer in the drip-and-ship model, particularly between primary stroke centers (PSCs) and comprehensive stroke centers (CSCs).
Drawing on practical experience and workflow analysis, this topic will further explore strategies to optimize interhospital collaboration, including standardized transfer protocols, regional coordination mechanisms, and real-time imaging sharing systems, with the goal of improving transfer efficiency and overall quality of stroke care.

Executive Summary：
Professor Liu is interested in stroke, neurosonography research and medical education. He also focus on the studies regarding post radiation neurovascular complications in head and neck cancer.

Lecture Abstract：
Large artery disease (LAD) is a common cause of ischemic stroke, and most cases are attributed to atherosclerosis. However, LAD may also result from non-atherosclerotic etiologies. Whether the prognosis and treatment of non-atherosclerotic LAD differ from those of atherosclerotic LAD remains an important clinical question. This session will briefly address this issue.

Executive Summary：
Hong-lie Jhou, MD, is an attending physician and interventional neurologist at the Neurological Institute of Changhua Christian Hospital. He earned his medical degree from Kaohsiung Medical University and completed his neurology residency, vascular neurology fellowship, and interventional neuroradiology fellowship at Changhua Christian Hospital. Dr. Jhou's clinical practice focuses on acute intra-arterial therapies and stroke care. He has authored over 15 peer-reviewed publications in stroke intervention and neurocritical care. His work involves both clinical practice and research in interventional neurology.

Lecture Abstract：
The management of ischemic stroke is evolving rapidly, particularly regarding reperfusion strategies. In the domain of thrombolysis therapy, options have expanded beyond traditional alteplase to include agents such as tenecteplase, with increasing evidence suggesting that alternative thrombolytic agents may improve patient outcomes. Beyond the intravenous route, intra-arterial thrombolysis remains a viable pathway to enhance prognosis. Furthermore, innovative nanomedicine approaches for thrombolytic therapy designed to precisely target thrombi and improve recanalization rates are currently enrolling patients in randomized controlled trials. Regarding endovascular therapy, while early 2025 results for distal medium vessel occlusion were neutral, ongoing randomized controlled trials are expected to identify specific subgroups that may still benefit. Similarly, the efficacy of endovascular therapy for patients with low National Institutes of Health Stroke Scale scores presenting with large vessel occlusion, as well as those in the extended window beyond twenty-four hours, remains a critical area of study awaiting further data from upcoming clinical trials. Integrating these updates is essential for optimizing selection and improving functional recovery in the hyperacute phase of stroke care.